Iambic Therapeutics, Inc. — Form D/A

Iambic Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2024-05-07. The offering totals $38.0M, of which $29.9M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-05-07
• Form: D/A
• Accession: 0001997038-24-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $38.0M
• Amount sold: $29.9M
• Remaining: $8.1M
• Investors: 8
• Date of first sale: 2024-04-15
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-511607

Issuer

• Name: Iambic Therapeutics, Inc.
• CIK: 0001997038
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 5627 OBERLIN DRIVE, SUITE 120 5627 Oberlin Drive, Suite 120, SAN DIEGO, CA, 92121
• Phone: (626) 592-2520

Officers, directors & promoters (28)

Showing 25 of 28 people.

Other filings by this issuer (5)

More

• CIK 1997038 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search